{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:45:21Z","timestamp":1784547921474,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s13300-024-01648-w","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T17:02:50Z","timestamp":1729702970000},"page":"2489-2498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Relation of Diabetes Complications to a New Interpretation of Glycaemic Variability from Continuous Glucose Monitoring in People with Type 1 Diabetes"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9537-4050","authenticated-orcid":false,"given":"Adrian H.","family":"Heald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Stedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Warner","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lleyton","family":"Belston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Paisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Jude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JMartin","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellena","family":"Habte-Asres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"issue":"6","key":"1648_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/BF01228130","volume":"14","author":"T Deckert","year":"1978","unstructured":"Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. Survival, causes of death, and complications. Diabetologia. 1978;14(6):363\u201370.","journal-title":"Diabetologia."},{"key":"1648_CR2","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386.","DOI":"10.1056\/NEJM199309303291401"},{"key":"1648_CR3","doi-asserted-by":"crossref","unstructured":"Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643\u201353.","DOI":"10.1056\/NEJMoa052187"},{"key":"1648_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40:994\u20139.","journal-title":"Diabetes Care"},{"issue":"5","key":"1648_CR5","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1177\/1932296819883885","volume":"14","author":"L Heinemann","year":"2020","unstructured":"Heinemann L, Freckmann G, M\u00fcller-Wieland D, Kellerer M. Critical reappraisal of the time-in-range: alternative or useful addition to glycated hemoglobin? J Diabetes Sci Technol. 2020;14(5):922\u20137.","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"1648_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The Diabetes Control and Complications Trial Research Group","year":"1995","unstructured":"The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968\u201383.","journal-title":"Diabetes"},{"issue":"10","key":"1648_CR7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.2337\/dc09-0109","volume":"32","author":"ES Kilpatrick","year":"2009","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care. 2009;32(10):1901\u20133.","journal-title":"Diabetes Care."},{"key":"1648_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2337\/dc15-2782","volume":"39","author":"FLAT-SUGAR Trial Investigators","year":"2016","unstructured":"FLAT-SUGAR Trial Investigators. Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus GLP-1 agonist in participants with type 2 diabetes at high cardiovascular risk. Diabetes Care. 2016;39:973\u201381.","journal-title":"Diabetes Care"},{"key":"1648_CR9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2337\/dc15-2782","volume":"39","author":"FLAT-SUGAR Trial Investigators","year":"2016","unstructured":"FLAT-SUGAR Trial Investigators. Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus GLP-1 agonist in participants with type 2 diabetes at high cardiovascular risk. Diabetes Care. 2016;39:973\u201381.","journal-title":"Diabetes Care"},{"key":"1648_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4093\/dmj.2015.39.4.273","volume":"39","author":"S Suh","year":"2015","unstructured":"Suh S, Kim JH. Glycemic variability: how do we measure it and why is it important? Diabetes Metab J. 2015;39:273\u201382.","journal-title":"Diabetes Metab J"},{"issue":"Suppl 2","key":"1648_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.12140","volume":"15","author":"F Cavalot","year":"2013","unstructured":"Cavalot F. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes. Diabetes Obes Metab. 2013;15(Suppl 2):3\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"1648_CR12","doi-asserted-by":"crossref","unstructured":"Leelarathna L, Evans ML, Neupane S, et al. Intermittently scanned continuous glucose monitoring for type 1 diabetes. N Engl J Med. 2022;387(16):1477\u201387.","DOI":"10.1056\/NEJMoa2205650"},{"issue":"11","key":"1648_CR13","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2337\/dc18-1581","volume":"41","author":"RM Bergenstal","year":"2018","unstructured":"Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring. Diabetes Care. 2018;41(11):2275\u201380.","journal-title":"Diabetes Care"},{"key":"1648_CR14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058\u201370.","journal-title":"Circ Res"},{"issue":"11","key":"1648_CR15","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","volume":"52","author":"L Quagliaro","year":"2003","unstructured":"Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52(11):2795\u2013804.","journal-title":"Diabetes"},{"key":"1648_CR16","doi-asserted-by":"publisher","first-page":"e59980","DOI":"10.7554\/eLife.59980","volume":"9","author":"AD Skol","year":"2020","unstructured":"Skol AD, Jung SC, Sokovic AM, et al. Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes. Elife. 2020;9:e59980.","journal-title":"Elife."},{"issue":"11","key":"1648_CR17","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.2337\/dc18-1131","volume":"41","author":"J Lu","year":"2018","unstructured":"Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care. 2018;41(11):2370\u20136.","journal-title":"Diabetes Care"},{"key":"1648_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00125-017-4423-z","volume":"61","author":"B Zinman","year":"2018","unstructured":"Zinman B, Marso SP, Poulter NR, et al. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61:48\u201357.","journal-title":"Diabetologia."},{"key":"1648_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00125-017-4422-0","volume":"61","author":"TR Pieber","year":"2018","unstructured":"Pieber TR, Marso SP, McGuire DK, on behalf of the DEVOTE StudGroup, et al. DEVOy TE3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality. Diabetologia. 2018;61:58\u201365.","journal-title":"Diabetologia."},{"issue":"14","key":"1648_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386.","journal-title":"N Engl J Med"},{"issue":"11","key":"1648_CR21","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1007\/s00125-020-05273-7","volume":"63","author":"JJ Zhou","year":"2020","unstructured":"Zhou JJ, Coleman R, Holman RR, Reaven P. Long-term glucose variability and risk of nephropathy complication in UKPDS, ACCORD and VADT trials. Diabetologia. 2020;63(11):2482\u20135.","journal-title":"Diabetologia"},{"issue":"10","key":"1648_CR22","doi-asserted-by":"publisher","first-page":"e3638","DOI":"10.1210\/clinem\/dgaa361","volume":"105","author":"E Scott","year":"2020","unstructured":"Scott E, Januszewski A, O\u2019Connell R, et al. Long-term glycaemic variability and vascular complications in Type 2 diabetes: post-hoc analysis of the FIELD study. J Clin Endocrinol Metab. 2020;105(10):e3638\u201349.","journal-title":"J Clin Endocrinol Metab."},{"key":"1648_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.diabet.2008.04.005","volume":"34","author":"J Bragd","year":"2008","unstructured":"Bragd J, Adamson U, B\u00e4cklund LB, Lins PE, Moberg E, Oskarsson P. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab. 2008;34:612\u20136.","journal-title":"Diabetes Metab."},{"key":"1648_CR24","doi-asserted-by":"crossref","unstructured":"The DECODE study group on behalf of the Europe an Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 1999;354:P617\u201321.","DOI":"10.1016\/S0140-6736(98)12131-1"},{"issue":"7367","key":"1648_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","volume":"325","author":"DAFNE Study Group","year":"2002","unstructured":"DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ. 2002;325(7367):746. https:\/\/doi.org\/10.1136\/bmj.325.7367.746.","journal-title":"BMJ"},{"key":"1648_CR26","unstructured":"https:\/\/www.england.nhs.uk\/london\/wp-content\/uploads\/sites\/8\/2019\/07\/dia-FreeStyle-Libre-training-pack-for-HCP-and-patients-052018.pdf. Accessed 30 April 2024"},{"key":"1648_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/dme.13911","volume":"37","author":"R Livingstone","year":"2020","unstructured":"Livingstone R, Boyle JG, Petrie JR. How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes? Diabet Med. 2020;37:513\u201321.","journal-title":"Diabet Med"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-024-01648-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:11:09Z","timestamp":1731474669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-024-01648-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1007\/s13300-024-01648-w","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adrian H Heald, Mike Stedman, John Warner Levy, Lleyton Belston, Angela Paisley, Reena Patel, Alison White, Edward Jude, J Martin Gibson, Hellena Habte-Asres, Martin Whyte and Angus Forbes have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants were attending the clinic of one of the authors (Adrian H Heald). The FreeStyle Libre data are available in its entirety as part of their usual care for analysis by the clinical team. All patients were given the option to opt out of their data being analysed. Such data analysis in relation to clinical care is acceptable under UK research ethics guidance. Patients whose data were analysed  were kept fully informed, in accordance with the UK guidance at . All data were full anonymised prior to analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}